Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
MMP-2 Antibody (8B4), mFluor Violet 610 SE, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NB200114MFV610
Description
MMP-2 Monoclonal antibody specifically detects MMP-2 in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDownSpecifications
MMP-2 | |
Monoclonal | |
mFluor Violet 610 SE | |
50mM Sodium Borate | |
Mouse | |
Protein G purified | |
RUO | |
Primary | |
Human, Mouse, Rat | |
Purified |
Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunoprecipitation, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown | |
8B4 | |
Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Knockdown Validated | |
72 kDa gelatinase, CLG4, CLG4A72 kDa type IV collagenase, collagenase type IV-A, EC 3.4.24, EC 3.4.24.24, Gelatinase A, matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IVcollagenase), matrix metalloproteinase 2 (gelatinase A, 72kD gelatinase, 72kD type IVcollagenase), Matrix metalloproteinase-2, matrix metalloproteinase-II, MMP-2, MMP-II, MONA, neutrophil gelatinase, TBE-1matrix metalloproteinase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IVcollagenase) | |
Activated recombinant human MMP-2. [Uniprot: P08253] | |
0.1 mL | |
Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Extracellular Matrix, HIF Target Genes, Hypoxia, Metastasis, Tumor Suppressors | |
4313 | |
Store at 4C in the dark. | |
IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction